Method Article
Engineered muscle tissue has great potential in regenerative medicine, as disease model and also as an alternative source for meat. Here we describe the engineering of a muscle construct, in this case from mouse myoblast progenitor cells, and the stimulation by electrical pulses.
Engineered muscle tissues can be used for several different purposes, which include the production of tissues for use as a disease model in vitro, e.g. to study pressure ulcers, for regenerative medicine and as a meat alternative 1. The first reported 3D muscle constructs have been made many years ago and pioneers in the field are Vandenburgh and colleagues 2,3. Advances made in muscle tissue engineering are not only the result from the vast gain in knowledge of biochemical factors, stem cells and progenitor cells, but are in particular based on insights gained by researchers that physical factors play essential roles in the control of cell behavior and tissue development. State-of-the-art engineered muscle constructs currently consist of cell-populated hydrogel constructs. In our lab these generally consist of murine myoblast progenitor cells, isolated from murine hind limb muscles or a murine myoblast cell line C2C12, mixed with a mixture of collagen/Matrigel and plated between two anchoring points, mimicking the muscle ligaments. Other cells may be considered as well, e.g. alternative cell lines such as L6 rat myoblasts 4, neonatal muscle derived progenitor cells 5, cells derived from adult muscle tissues from other species such as human 6 or even induced pluripotent stem cells (iPS cells) 7. Cell contractility causes alignment of the cells along the long axis of the construct 8,9 and differentiation of the muscle progenitor cells after approximately one week of culture. Moreover, the application of electrical stimulation can enhance the process of differentiation to some extent 8. Because of its limited size (8 x 2 x 0.5 mm) the complete tissue can be analyzed using confocal microscopy to monitor e.g. viability, differentiation and cell alignment. Depending on the specific application the requirements for the engineered muscle tissue will vary; e.g. use for regenerative medicine requires the up scaling of tissue size and vascularization, while to serve as a meat alternative translation to other species is necessary.
1. Culture of Murine Myoblast Progenitor Cells or C2C12 Cells
Note: coat for 2 hr at Room Temperature and remove the Matrigel by aspiration.
Notes: - Per triple 150 cm2 the number of cells will be approximately 4.5 x 106 cells.
- Use vials from different isolations to mix them to obtain a mixed population of cells at time of seeding.
Note: If you choose not to work with primary cells, C2C12 myoblasts are a good alternative.
2. Engineering Skeletal Muscle Tissues
Notes: - Only use the soft side of the Velcro and face this side upwards.
- Make sure that the rooftops face each other.
- Only cover the Velcro with silicon glue, do not spread glue throughout the well.
- For later electrical stimulation it is relevant to align the constructs in vertical direction of the well plate (along the long axis).
Note: leave everything on ice.
Notes: - Perform each step on ice! Matrigel and collagen will readily gel at increasing temperature.
- Mind that the color indeed is pink! An increase in pH will also induce rapid gelation.
- Final concentration of collagen: 1.6 mg/ml.
Note: - Depending on the activity of the cells the number of cells per construct needs to be adjusted. Typically, the number of cells lies between 750,000 and 1,250,000 cells per construct.
Note: -Do not make any vigorous movements when handling the plates.
3. Electrical Stimulation
Note: Electrodes are placed parallel alongside the muscle construct (Figure 2).
Note: We generally use 4 V/CM, 6ms pulses at a frequency of 2Hz. Change culture medium every 24 hr during stimulation.
The end product will be muscle constructs as indicated in Figure 3. The size of the tissue will be approximately 8 mm long, 2 mm wide and 0.5 mm thick. Electrical stimulation during differentiation will change the expression of myosin heavy chain isoforms, but does not greatly enhance the differentiation process as induced by the differentiation medium 8, but electrical stimulation can also be applied at the end of the process to check for functionality of the muscle, because a muscle with fully developed sarcomeres will be able to contract upon an electrical pulse.
Differentiation and maturation can also be analyzed using quantitative PCR for gene expression evaluation and staining for muscle maturation markers or cross striation development (e.g. staining for alpha actinin) on either sections made from the tissues or whole mount stained tissue samples. Muscle maturation and differentiation related genes and myosin heavy chain expression include e.g. MyoD, myogenin, MFR4 and MLP, and MYH 1, 2, 4 and 8 8. Proof that the muscle tissue that is formed indeed is muscle tissue, based on gene expression, immunohistochemical stainings and contraction induction by electrical stimulation, has been published previously 8 and a figure with stained cross sections of muscle tissues made from myoblast progenitor cells and C2C12 cells from this paper is displayed in Figure 4.
Solution | Volume (if making 10 muscles) in μl |
Collagen (3.2 mg/ml, diluted with 0.02% acetic acid) | 2570 (51.3%) |
NaOH (0.5M) | 10 (0.2%) |
Matrigel | 430 (8.6%) |
Growth medium | 2,000 (39.9%) |
total | 5,010 (should suffice with enough for spilling and pipetting loss) |
Table 1. mixture of cells and gel for the generation of a tissue engineered muscle construct.
Figure 1. Cutting the pieces of Velcro.
Figure 2. A picture taken from the bottom of a muscle construct in a well of a 6-well plate showing the placement of the electrodes. The electrodes (indicated with the white arrows) are placed parallel to the muscle constructs.
Figure 3. A tissue engineered muscle in between two pieces of Velcro in a 6-well culture plate.
Figure 4. Typical examples of cross-striations in C2C12 (A) and MPC (B) in engineered skeletal muscle tissues. Frozen sections of non-stimulated mBAMs (day 8 of differentiation) were stained for sarcomeric α-actinin (red), sarcomeric myosin (green) and nuclei (blue). (Aa-Ab and Ba-Bb) Magnifications of boxed areas in (A, B) α-Actinin (red) and sarcomeric myosin (green). Reprinted with permission from 8. Click here to view larger figure.
The engineering of muscle tissues has great potential for the use as a disease model, for drug screening, in regenerative medicine and for meat production. However, the requirements for these applications vary. We chose to work with a combination of collagen and matrigel, because collagen allows for cell alignment and because the myoblast progenitor cells require the presence of basement membrane derived proteins as determined in previous 2D studies 12. Moreover, fibrin gels have been tested in our laboratory and seem not to support the C2C12 and myoblast progenitor cells as does the mixture of collagen and Matrigel™ and especially do not lead to tissue compaction 14. The model as described here has been used already in studies on pressure ulcer damage while using a cell line 15. For regenerative medicine applications, the translation to human satellite cells has recently been made 6,16. In addition, as an alternative source for meat consumption the technique has great potential 1. In our opinion however, the current technology needs to advance to a next stage to further its use in the clinic as well as for consumption. For example, the differentiation stops at around the neonatal stage and also force production is much less than a muscle produces in vivo. Additionally, although mouse, rat and human stem cells can be implemented in the 3D constructs, the isolation and especially the differentiation and maturation of farm animal derived muscle stem cells is not developed that far yet1. Also, the use of Matrigel and animal derived serum needs to be omitted 1. To further the application in regenerative medicine, the tissue size has to be increased, and requires (neo) vascularization and use of perfusion bioreactor systems to overcome oxygen and nutrient diffusion limitations. Some initial vascularization studies on small constructs have been done in the past years 9,17,18.
The authors have nothing to disclose.
The authors want to thank Yabin Wu for culturing the tissues presented in Figure 2, the picture was taken by Bart van Overbeeke. The work was financially supported by SenterNovem, grant ISO 42022.
Name | Company | Catalog Number | Comments |
Matrigel-growth factor reduced | Beckton and Dickinson | ||
DMEM (high glucose)* | Gibco | 42430 | |
Advanced DMEM | Gibco | 12491 | |
Horse serum | Gibco | 65050-122 | |
Fetal bovine serum | Greiner | 758075 | |
0.45 and 0.22 μm syringe filter* | Whatmann (Schleicher and Scheull) | 10462100 | |
L-glutamine | Gibco | 25030024 | |
Penicillin/streptomycin | Gibco | 10378016 | |
Amphotericin | Gibco | 15290-018 | |
Culture plastic | Greiner | Includes culture flasks and pipets | |
Chick embryo extract | United States Biological | C3999 | |
Pasteur pipet* | Hilgenberg | Pasteur pipettes, with constriction, with cotton, open tip L: 230 mm with tip diameter of 0,9 - 1,1 mm | |
Pasteur pipet* | Hilgenberg | Pasteur pipettes, with constriction, with cotton, open tip L: 230 mm with tip diameter of 1,4 - 1,6 mm | |
Pasteur pipet | VWR | 612-1702 | |
Collagenase type I* | Sigma | C0130-16 | |
40 μm cell strainer* | BD Falcon | 352340 | |
19G needle | |||
Elastomer | Dow Corning corporation | 3097358-1004 | Silastic MDX 4-4210# |
Curing agent | Dow Corning corporation | Silastic MDX 4-4210# | |
Velcro | Regular store | You can buy this at a regular store, only use the soft side | |
Collagen type I, rat tail | BD Biosciences | 3544236 | |
C-Pace EP Culture Pacer | Ionoptix | ||
6-well culture dishes for electrical stimulation | Beckton Dickinson-Falcon | BD Falcon #353846 | |
C-Dish culture dish electrodes | Ionoptix | ||
* Needed for the isolation of cells (point 1.1) # Together in one kit |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone